Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Alogabat is a positive allosteric modulator of the GABAA receptor (GABAAR).1 It potentiates GABA-stimulated currents in X. laevis oocytes expressing α5β3γ2 and α5β3γ3 subunit-containing GABAARs (EC50s = 12 and 20 nM, respectively). It is selective for α5β3γ2 subunit-containing GABAARs over α1β3γ2, α2β3γ2, and α3β3γ2 subunit-containing GABAARs (Kis = 10.9, 415.8, 178.3, and 113 nM, respectively) and is greater than 917-fold selective over a panel of 56 receptors, ion channels, and enzymes at 10 µM. Alogabat (60-120 mg/kg, i.p.) reduces repetitive self-grooming behavior in a BTBR mouse model of autism spectrum disorder (ASD). It inhibits seizures induced by pentylenetetrazole (PTZ; Item No. 18682) in rats when administered orally at a dose of 15 or 30 mg/kg.
WARNING This product is not for human or veterinary use.
1. Preclinical pharmacology of alogabat: A novel GABAA-